Benefícios da isoflavonas de soja na menopausa: uma revisão de literatura

Abstract

Menopause has been affecting women under 40 years of age, at risk of premature death, neurological diseases, psychosexual dysfunction, mood disorders, osteoporosis, ischemic heart disease and infertility. The estrogenic and antiestrogenic action of some plant-derived substances has been known for some decades, and for this reason they are called phytoestrogens. Isoflavones are phytoestrogens being widely disseminated in the plant kingdom. Its highest concentrations are in legumes, especially in soybeans, being a beneficial preventive in menopause. The objective of this study is to verify by means of a bibliographic review the benefits of soy isoflavones in menopause. The present study consists of an exploratory and descriptive study carried out through a review of the literature. The data were collected through searches in virtual health databases, in the Virtual Health Library - VHL. Isoflavones bring benefits to women in menopause, so there is a great acceptability for them, becoming a therapeutic choice of hormone replacement. Isoflavones may, however, benefit patients who decide not to use estrogens or who have side effects from the use of these hormones, for which even partial relief may be sufficient. Isoflavone at a dose of 100 mg / day can be used as an alternative to attenuate climacteric symptoms. In addition, isoflavone is an alternative to attenuate the climacteric symptoms of patients at greater risk of developing gynecological cancer and those who are contraindicated for the use of estrogen. The consumption of isoflavones, bring many benefits to women's health, as it prevents against metabolic diseases, early menopause. Therefore, its consumption is important because the isoflavones are derived from soy, containing high amounts of proteins, fibers and phytosteroids. Therefore, the use of isoflavone is considered an effective therapy for the relief of climacteric symptoms, presenting an alternative for women at this stage.